Skip to main content
. 2022 Sep 8;52(12):e13866. doi: 10.1111/eci.13866

TABLE 2.

Age‐ and sex‐specific percentile values for serum sex steroids and sex steroid‐binding globulin

(A) Total estradiol (pmol/L)
Men Women
Age‐groups N 5th 25th 50th 75th 95th Age‐groups N 5th 25th 50th 75th 95th
45–49 year 212 41.93 63.70 86.92 109.43 155.55 45–49 year 245 18.35 32.37 165.30 512.50 1719.00
50–54 year 391 46.90 71.62 90.78 115.80 154.95 50–54 year 456 18.35 18.35 40.75 129.98 800.20
55–59 year 471 45.09 74.06 94.47 115.70 160.10 55–59 year 582 18.35 18.35 18.49 43.60 85.84
60–64 year 300 54.02 80.51 99.78 125.73 161.30 60–64 year 387 18.35 18.35 27.80 45.30 79.32
65–69 year 49 64.69 83.17 104.40 129.30 165.16 65–69 year 51 18.35 18.35 32.59 50.32 110.60
70–74 year 39 64.79 95.28 123.20 131.90 155.29 70–74 year 41 18.35 24.28 38.43 51.62 138.20
75–79 year 23 51.11 75.21 114.40 125.45 161.81 75–79 year 29 18.35 18.96 34.40 44.02 68.68
(B) Total testosterone (nmol/L)
Men Women
Age‐groups N 5th 25th 50th 75th 95th Age‐groups N 5th 25th 50th 75th 95th
45–49 year 212 10.05 14.43 17.98 22.97 28.00 45–49 year 245 0.37 0.59 0.80 1.06 1.66
50–54 year 391 9.97 13.97 17.27 21.79 27.63 50–54 year 452 0.38 0.57 0.80 1.10 1.63
55–59 year 471 9.60 13.05 16.67 20.82 27.70 55–59 year 580 0.34 0.55 0.73 1.01 1.70
60–64 year 298 9.25 12.78 16.31 20.43 26.95 60–64 year 386 0.38 0.59 0.82 1.12 1.68
65–69 year 49 9.55 12.46 17.26 20.30 27.82 65–69 year 51 0.36 0.59 0.86 1.11 1.53
70–74 year 39 9.61 12.15 15.77 19.43 24.08 70–74 year 41 0.30 0.55 0.81 1.13 1.61
75–79 year 23 10.34 12.01 13.46 18.00 22.84 75–79 year 28 0.31 0.60 0.78 1.14 2.74
(C) cFAI
Men Women
Age‐groups N 5th 25th 50th 75th 95th Age‐groups N 5th 25th 50th 75th 95th
45–49 year 212 0.33 0.40 0.49 0.57 0.71 45–49 year 245 0.004 0.009 0.013 0.018 0.028
50–54 year 391 0.30 0.39 0.45 0.53 0.70 50–54 year 452 0.004 0.009 0.013 0.021 0.034
55–59 year 471 0.25 0.35 0.41 0.49 0.62 55–59 year 580 0.005 0.009 0.014 0.020 0.039
60–64 year 298 0.26 0.33 0.40 0.47 0.60 60–64 year 386 0.006 0.011 0.016 0.023 0.037
65–69 year 49 0.23 0.29 0.35 0.43 0.55 65–69 year 51 0.006 0.011 0.014 0.022 0.032
70–74 year 39 0.19 0.25 0.31 0.40 0.52 70–74 year 41 0.005 0.009 0.017 0.021 0.038
75–79 year 23 0.24 0.27 0.28 0.34 0.37 75–79 year 28 0.005 0.007 0.012 0.018 0.035
(D) SHBG (nmol/L)
Men Women
Age‐groups N 5th 25th 50th 75th 95th Age‐groups N 5th 25th 50th 75th 95th
45–49 year 212 18.92 28.57 37.85 47.68 66.01 45–49 year 245 26.18 45.27 67.08 92.76 171.94
50–54 year 391 19.21 29.53 38.61 50.11 65.40 50–54 year 456 25.38 42.26 59.41 82.89 128.95
55–59 year 471 21.61 31.68 41.12 50.75 70.68 55–59 year 582 24.70 39.53 54.89 76.49 115.51
60–64 year 300 20.40 31.76 41.73 52.78 76.27 60–64 year 387 25.79 39.61 52.31 71.97 109.15
65–69 year 49 25.36 35.48 43.48 58.55 90.36 65–69 year 51 32.66 41.40 53.65 69.00 96.64
70–74 year 39 24.00 38.45 47.32 63.30 91.73 70–74 year 41 27.57 38.93 49.29 75.93 110.80
75–79 year 23 32.03 40.48 49.14 64.64 89.16 75–79 year 29 34.23 52.26 74.90 86.62 132.14
(E) DHEA (nmol/L)
Men Women
Age‐groups N 5th 25th 50th 75th 95th Age‐groups N 5th 25th 50th 75th 95th
45–49 year 209 6.85 12.67 17.77 25.32 46.77 45–49 year 241 5.12 10.14 14.71 23.24 45.23
50–54 year 389 6.10 9.45 14.42 20.84 38.67 50–54 year 450 4.83 10.17 14.94 22.03 38.70
55–59 year 459 5.07 8.51 12.69 18.19 30.93 55–59 year 573 4.54 8.67 13.24 19.18 32.92
60–64 year 294 4.25 7.23 10.15 16.40 27.64 60–64 year 384 4.28 8.52 12.92 19.34 34.77
65–69 year 49 3.75 6.28 9.12 12.62 23.47 65–69 year 51 3.08 7.34 9.19 13.22 23.78
70–74 year 39 2.74 3.91 6.42 10.05 19.62 70–74 year 41 2.63 4.13 7.28 11.98 22.34
75–79 year 23 2.47 3.39 4.61 9.72 14.45 75–79 year 27 2.20 3.15 5.60 8.88 16.88
Men Women
Age‐groups N 5th 25th 50th 75th 95th Age‐groups N 5th 25th 50th 75th 95th
45–49 year 193 2027.79 3487.16 4835.29 6171.53 7458.33 45–49 year 242 786.85 1878.14 3067.44 4197.49 6546.83
50–54 year 360 1613.14 2839.77 4055.80 5367.02 7030.06 50–54 year 447 866.30 1662.73 2545.95 3771.91 5684.64
55–59 year 455 1175.83 2472.76 3612.80 5043.47 6815.23 55–59 year 577 660.39 1408.54 2323.50 3317.62 5200.07
60–64 year 286 946.81 1872.69 2913.95 4264.78 7004.31 60–64 year 386 649.74 1313.61 2016.49 2923.86 5072.82
65–69 year 49 788.18 1470.75 2393.82 3464.91 5564.23 65–69 year 51 522.88 1034.04 1592.58 2745.01 4593.76
70–74 year 39 668.93 1057.61 1508.26 2525.77 4943.30 70–74 year 41 251.97 862.73 1494.59 2077.82 3038.15
75–79 year 23 558.24 970.90 1491.19 2573.66 4170.95 75–79 year 29 136.07 541.30 1065.05 1588.92 3108.19
(G) Androstenedione (nmol/L)
Men Women
Age‐groups N 5th 25th 50th 75th 95th Age‐groups N 5th 25th 50th 75th 95th
45–49 year 211 2.00 3.04 3.86 4.75 8.01 45–49 year 245 1.32 2.30 3.33 4.39 7.33
50–54 year 391 2.02 2.81 3.48 4.49 6.55 50–54 year 451 1.26 2.15 2.97 3.98 6.17
55–59 year 469 1.79 2.55 3.19 4.30 6.18 55–59 year 577 1.17 1.80 2.49 3.30 5.57
60–64 year 298 1.73 2.43 3.10 4.14 5.87 60–64 year 386 1.12 1.84 2.53 3.39 5.41
65–69 year 49 1.47 2.07 2.73 3.67 5.85 65–69 year 50 1.18 1.65 2.28 3.01 4.50
70–74 year 39 1.25 1.76 2.60 3.56 4.74 70–74 year 41 0.94 1.57 1.79 2.64 4.64
75–79 year 23 1.28 1.93 2.18 3.03 4.20 75–79 year 29 0.78 1.37 1.80 2.42 3.60

Abbreviations: N; number, cFAI; calculated free androgen index, SHBG; sex steroid‐binding globulin, DHEA; dehydroepiandrosterone, DHEAS; dehydroepiandrosterone sulfate.